Henry W LimSummaryAffiliation: Henry Ford Hospital Country: USA Publications
| Collaborators
|
Detail Information
Publications
Remembrance: Irwin FreedbergHenry W Lim
Department of Dermatology, Henry Ford Hospital, Detroit, Michigan 48202, USA
J Invest Dermatol 126:522. 2006
Sunlight, tanning booths, and vitamin DHenry W Lim
Department of Dermatology at Henry Ford Hospital, Detroit, Michigan, USA
J Am Acad Dermatol 52:868-76. 2005
Commentary: A responsible approach to maintaining adequate serum vitamin D levelsHenry W Lim
Department of Dermatology at Henry Ford Hospital, Detroit, Michigan, USA
J Am Acad Dermatol 57:594-5. 2007
SunscreensLaura Thomas
Wayne State University School of Medicine, USA
J Drugs Dermatol 2:174-7. 2003
Risk factors for presumptive melanoma in skin cancer screening: American Academy of Dermatology National Melanoma/Skin Cancer Screening Program experience 2001-2005Matthew S Goldberg
Mount Sinai School of Medicine, New York, NY, USA
J Am Acad Dermatol 57:60-6. 2007....
Economic evaluation of the US Environmental Protection Agency's SunWise program: sun protection education for young childrenJessica W Kyle
ICF International, 1725 Eye St, NW, Suite 1000, Washington, DC, USA
Pediatrics 121:e1074-84. 2008..The objectives of this study were to assess the health benefits of the SunWise School Program and use economic analysis to determine the program's net benefits and cost-effectiveness...
Scientific and regulatory issues related to indoor tanningHenry W Lim
Department of Dermatology, Henry Ford Hospital, Detroit, Michigan, USA
J Am Acad Dermatol 51:781-4. 2004
Photoprotection by window glass, automobile glass, and sunglassesChanisada Tuchinda
Department of Dermatology, Henry Ford Hospital, Detroit, Michigan, USA
J Am Acad Dermatol 54:845-54. 2006..Factors affecting UV-protective properties of glass are glass type, glass color, interleave between glass, and glass coating. In this article, photoprotection by window glass, automobile glass, and sunglasses is reviewed...
308-nm excimer laser for the treatment of lymphomatoid papulosis and stage IA mycosis fungoidesAndrew P Kontos
Photodermatol Photoimmunol Photomed 22:168-71. 2006
Tacrolimus ointment 0.1% alone and in combination with medium-dose UVA1 in the treatment of palmar or plantar psoriasisJennifer Rivard
Department of Dermatology, Henry Ford Hospital, Detroit, MI 48202, USA
J Drugs Dermatol 5:505-10. 2006..No dramatic changes in plaque thickness or scaling were seen with either tacrolimus alone or with the combination of tacrolimus and medium dose UVA1 on palmar or plantar psoriasis...
UVA1 phototherapy for cutaneous diseases: an experience of 92 cases in the United StatesChanisada Tuchinda
Department of Dermatology, Henry Ford Hospital, Detroit, MI 48202, USA
Photodermatol Photoimmunol Photomed 22:247-53. 2006..The efficacy and safety of UVA1 (340-400 nm) phototherapy were established by studies from European countries...
Comparison of broadband UVB, narrowband UVB, broadband UVA and UVA1 on activation of apoptotic pathways in human peripheral blood mononuclear cellsChanisada Tuchinda
Department of Dermatology, Henry Ford Hospital, Detroit, MI, USA
Photodermatol Photoimmunol Photomed 23:2-9. 2007..The aim of this study is to analyze the effects of different UV wavelengths that are used clinically on normal human peripheral blood mononuclear cells (PBMCs)...
Photoadaptation of vitiliginous skin to targeted ultraviolet B phototherapyJennifer Rivard
Department of Dermatology, Henry Ford Hospital, Detroit, MI 48202, USA
Photodermatol Photoimmunol Photomed 23:258-60. 2007..In this pilot study, five patients with Fitzpatrick skin phototypes IV-VI with vitiligo received six treatments of targeted UVB phototherapy over a 3-week period...
Effects of visible light on the skinBassel H Mahmoud
Multicultural Dermatology Center, Department of Dermatology, Henry Ford Hospital, Detroit, MI, USA
Photochem Photobiol 84:450-62. 2008..Conversely, because of its cutaneous biologic effects, visible light is used for the treatment of a variety of skin diseases and esthetic conditions in the form of lasers, intense pulsed light and photodynamic therapy...
Narrowband UVB phototherapy for early-stage mycosis fungoidesRaechele Cochran Gathers
Department of Dermatology, Henry Ford Health System, Detroit, MI 48202-2689, USA
J Am Acad Dermatol 47:191-7. 2002..Upon discontinuation of treatment, 4 patients with CR relapsed, with a mean time to relapse of 12.5 weeks. CONCLUSION: NB-UVB is a viable, comparably safe, and easily administered alternative in the management of early stage MF...
Increased expression of CTLA-4 in malignant T-cells from patients with mycosis fungoides -- cutaneous T cell lymphomaHenry K Wong
Department of Dermatology, Henry Ford Hospital, Detroit, Michigan 48202, USA
J Invest Dermatol 126:212-9. 2006..These findings reveal an abnormal regulation of CTLA-4 expression in MF and show that PBMCs from patients with MF have properties that are divergent from those of normal T cells...
Novel emerging sunscreen technologiesChanisada Tuchinda
Department of Dermatology, Henry Ford Hospital, Detroit, MI 48303, USA
Dermatol Clin 24:105-17. 2006..With the advances in technologies, many new UV filters have been developed recently. These have improved efficacy and safety. This article reviews these new filters, along with regulatory issues in the United States...
Polymorphous light eruption in African Americans: pinpoint papular variantAndrew P Kontos
Department of Dermatology, Henry Ford Health System, Detroit, MI 48202, USA
Photodermatol Photoimmunol Photomed 18:303-6. 2002..CONCLUSION: Recognition of this pinpoint papular variant of PMLE in dark-skinned individuals is important in the evaluation and management of these patients...
Classification and evaluation of photodermatosesSharam Samson Yashar
Department of Dermatology, Henry Ford Health System, Detroit, Michigan 48202, USA
Dermatol Ther 16:1-7. 2003..Skin biopsies and laboratory investigations, such as antinuclear antibody (ANA) panels and porphyrin profiles, may be required to further confirm the diagnosis...
Narrow-band ultraviolet B treatment for vitiligo, pruritus, and inflammatory dermatosesSharam Samson Yashar
Department of Dermatology, Henry Ford Health System, Detroit, MI 48202, USA
Photodermatol Photoimmunol Photomed 19:164-8. 2003..Long-term adverse effects and cost-benefit analysis of NB-UVB therapy compared to other treatment modalities remain to be determined...
Cutaneous diseases in AsiansChai Sue Lee
Department of Dermatology, Henry Ford Health System, 2799 West Grand Boulevard, Detroit, MI 48202, USA
Dermatol Clin 21:669-77. 2003..Awareness of these less common cutaneous disorders can be helpful, especially for clinicians who work in areas with a large Asian population...
UVA-1 as a treatment for scleredemaJennifer J Janiga
Department of Dermatology, Henry Ford Hospital, 2799 West Grand Boulevard, Detroit, MI 48202, USA
Photodermatol Photoimmunol Photomed 20:210-1. 2004..Scleredema is a rare disease that is difficult to treat. Many therapies have been tried with varied and somewhat inconsistent results. Here we report two cases of scleredema successfully treated with low-dose UVA-1...
Topical calcipotriene and narrowband ultraviolet B in the treatment of vitiligoPrisana Kullavanijaya
Department of Dermatology, Henry Ford Hospital, 2999 West Grand Boulevard, Detroit, MI 48202, USA
Photodermatol Photoimmunol Photomed 20:248-51. 2004..No side effects were noted. CONCLUSION: Combination therapy of topical calcipotriene and NB-UVB is a therapeutic option that could be considered in the management of patients with vitiligo...
Photoprotection by sunscreens with topical antioxidants and systemic antioxidants to reduce sun exposureRichard F Edlich
Plastic Surgical Research Program, University of Virginia Health System, Charlottesville, Virginia, USA
J Long Term Eff Med Implants 14:317-40. 2004..The Skin Cancer Foundation, the only national and international nonprofit organization concerned exclusively with cancer of the skin, is playing a leadership role in eliminating skin cancer in our world...
PhotoprotectionPrisana Kullavanijaya
Department of Dermatology, Henry Ford Hospital, Detroit, MI 48202, USA
J Am Acad Dermatol 52:937-58; quiz 959-62. 2005..All of the above are reviewed in this article. LEARNING OBJECTIVE: At the conclusion of this learning activity, participants should be able to provide an overview of all aspects of photoprotection...
Transverse melanonychia secondary to total skin electron beam therapy: a report of 3 casesKathryn E Quinlan
Department of Dermatology, Henry Ford Hospital, Detroit, Michigan 48202, USA
J Am Acad Dermatol 53:S112-4. 2005..We report 3 cases of transverse melanonychia secondary to total skin electron beam therapy in patients who were treated for mycosis fungoides...
Ultraviolet phototherapy for pruritusJennifer Rivard
Department of Dermatology, Henry Ford Hospital, Detroit, Michigan 48202, USA
Dermatol Ther 18:344-54. 2005..Various mechanisms of action for phototherapy have been posited. Treatment limitations, side effects, and common dosing protocols are reviewed...
Current sunscreen issues: 2007 Food and Drug Administration sunscreen labelling recommendations and combination sunscreen/insect repellent productsCamile L Hexsel
Department of Dermatology, Henry Ford Hospital, Detroit, Michigan, USA
J Am Acad Dermatol 59:316-23. 2008..It may be prudent to follow the same approach of our Canadian colleagues of discontinuing combination products until more investigations are available...
